GABAergic function in detoxified heroin addicts: Relationship to anxiety disorders

Psychiatry Research

Volumn 77, Issue 2, 1998, Pages 89-96

  Gerra, Gilberto ^a   Ferri, Mila ^b   Zaimovic, Amir ^a   Giucastro, Giuliano ^a   Palladino, Mariella ^a   Sartori, Roberto ^a   Delsignore, Roberto ^c   Maestri, Dante ^d   Marzocchi, Gianfranco ^b   Brambilla, Francesca ^e  

^a Centra Studi Farmacotossicodipendenze   (Italy)

^b AUSL Modena   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d Ospedale di Parma   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Anxiety disorder; Baclofen; GABA; Growth hormone; Opioid system; Substance abuse

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; GROWTH HORMONE;

ADULT; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DETOXIFICATION; DRUG ABUSE; GABAERGIC SYSTEM; HEROIN DEPENDENCE; HORMONE RESPONSE; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; ANXIETY DISORDERS; BACLOFEN; GABA AGONISTS; HEROIN; HEROIN DEPENDENCE; HUMANS; MALE; METABOLIC DETOXICATION, DRUG; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, GABA;

EID: 0032498637     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(97)00147-9     Document Type: Article

References (31)

1. Arenas, E., Marsal, J., Alberch, J., 1980. GABA-A and GABA-B antagonists prevent the opioid inhibition of endogenous acetylcholine release evoked by glutamate from rat neostriatal slices. Neuroscience Letters 120, 201-204.
2. Balon, R., Petty, F., Yeragani, V.K., Kramer, G.L., Pohl, R., 1993. Intravenous sodium lactate decreases plasma GABA levels in man. Psychopharmacology 110, 368-370.
3. Black, D.W., Noyes, R., Jr., Pfohl, B., Goldstein, R.B., Blum, N., 1993. Personality disorder in obsessive-compulsive volunteers, well comparison subjects, and their first-degree relatives. [Italian translation by Maggini, C., Piccini, G. (1994)]. American Journal of Psychiatry 150, 1226-1232.
4. Bowery, N.G., Hill, D.R., R., Hudson, A.I., Doble, A., Middlemiss, D.N., Shaw, J., Turnbull, M., 1980. Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature 283, 92-98.
5. Brambilla, F., Carito, M., Zanoboni, A., Cella, S.G., Muller, E.E., 1988. Lisuride-induced stimulation of growth hormone release and inhibition of prolactin secretion in heroin addicted subjects and controls. Neuroendocrinology Letters 6, 393-398.
6. Brambilla, F., Casanueva, F., Lovati, C., Penalva, A., Madeddu, A., Martinez-Campos, A., Muller, E.E., 1981. Lack of tolerance in heroin addicts to the neuroendocrine effects of an enkephalin analogue. Life Sciences 29, 493-501.
7. Brambilla, F., Lampertico, M., Panerai, A., Sali, I., Salerno, F., Muller, E.E., 1984. Effects of clonidine on the secretion of anterior pituitary hormones in heroin addicts and normal volunteers. Psychiatry Research 13, 295-304.
8. Chiodera, P., Volpi, R., Coiro, V., Barilli, L., Rossi, G., Roti, E., 1983. Naloxone does not alter the effect of a gamma-aminobutyric acid derivative, baclofen, on GH release in man. Journal of Endocrinological Investigation 6, 381-384.
9. Dingledine, R., Iversen, L.L., Breuker, E., 1978. Naloxone as a GABA antagonist: evidence from iontophoretic receptor binding and convulsant studies. European Journal of Pharmacology 47, 19-27.
10. Eyre, S.L., Rounsaville, B.J., Kleber, H.D., 1982. History of childhood hyperactivity in a clinic population of opiate addicts. Journal of Nervous and Mental Disease 170, 5229-5234.
11. Fishbein, D.H., Lozowsky, D., Jaffe, J.H., 1989. Impulsivity, aggression and neuroendocrine responses to serotoninergic stimulation in substance abusers. Biological Psychiatry 25, 1049-1067.
12. Gerra, G., Caccavari, R., Fontanesi, B., Delsignore, R., Fertonani-Affini, G., Marcato, A., Maestri, D., Avanzini, P., Perna, G., Brambilla, F., 1994. Alpha-2-adrenoceptor sensi-tivity in heroin addicts with and without previous attention deficit disorder/hyperactivity and conduct disorder. Neuropsychobiology 30, 15-19.
13. Gerra, G., Fertonani, G., Tagliavini, P., Zaimovic, A., Delsignore, R., Maestri, D., Avanzini, P., Caccavari, R., Brambilla, F., 1995. Serotonin function in detoxified heroin abusers: prolactin and cortisol responses to fenfluramine challenge. Psychiatry Research 58, 153-160.
14. Goodman, W.K., Price, L.H., Rasmussen, S.A., Mazure, C., Fleischman, R., Hill, D.R., Heninger, G.R., Charney, D.S., 1989. The Yale-Brown Obsessive Compulsive Scale (YBOCS) Part 1: use and reliability. Archives of General Psychiatry 46, 1006-1011.
15. Graeff, F.G., Silveira, M.C., Nogueira, M.C., Audi, E.A., Oliveira, R.M., 1993. Role of the amygdala and periaqueductal gray in anxiety and panic. Behaviour and Brain Research 58, 123-131.
16. Hamilton, M., 1959. The assessment of anxiety states by rating. British Journal of Medical Psychology 32, 50-55.
17. Hunt, C., Andrews, G., 1992. Measuring personality disorder: the use of self-report questionnaires. Journal of Personality Disorders 6, 125-133.
18. Lader, M., 1994. Anxiety or depression during withdrawal of hypnotic treatments. Journal of Psychosomatic Research 1, 113-123.
19. Lucey, J.V., Butcher, G., O'Flynn, K., Clare, A.W., Dinan, G., 1994. The growth hormone response to baclofen in obsessive compulsive disorder: does the GABA-B receptor mediate obsessive anxiety? Pharmacopsychiatry 27, 23-26.
20. Luthar, S.S., Anton, S.F., Merikangas, K.R., Rounsaville, B.J., 1992. Vulnerability to substance abuse and psychopathology among siblings of opioid abusers. Journal of Nervous and Mental Disease 180, 153-161.
21. Milin, R., Halikas, J.A., Meller, J.E., Morse, C., 1991. Psychophathology among substance abusing juvenile offenders. Journal of the American Academy of Child and Adolescent Psychiatry 30, 569-574.
22. Monteleone, P., Maj, M., Iovino, M., Forziati, D., Veltro, F., Steardo, L., 1988. Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: neuroendocrine evidence for a GABA disturbance in schizophrenia. Psychiatry Research 26, 1-9.
23. Moroni, F., Cheney, D.L., Peralta, E., Costa, E., 1978. Opiate receptors agonists as modulators of gamma-aminobutyric acid turnover in the nucleus caudatus, globus pallidus and substantia nigra of the rat. Journal of Pharmacology and Experimental Therapeutics 207, 870-877.
24. Munjack, D.J., Baltazar, P.L., Bohm, P.B., Cabe, D.D., Appleton, A.A., 1990. Clonazepam in the treatment of social phobia: a pilot study. Journal of Clinical Psychiatry 51, 35-40.
25. O'Flynn, K., Dinan, T.G., 1993. Baclofen-induced growth hormone release in major depression: relationship to dexamethasone suppression test result. American Journal of Psychiatry 150, 1728-1730.
26. Ontiveros, A., Fontaine, R., 1990. Social phobia and clonazepam. Canadian Journal of Psychiatry 35, 439-441.
27. Roy-Byrne, P.P., 1992. Integrated treatment of panic disorder. American Journal of Medicine 92, S.
28. Sawynok, J., La Bella, F.S., 1981. GABA and baclofen potentiate the K ± evoked release of methionine-enkephalin from rat striatal slices. European Journal of Pharmacology 70, 103-110.
29. Spitzer, R.L., Williams, J.B.W., Gibbon, M., First, M.B., 1990. Structural Clinical Interview for DSM-III-R. American Psychiatric Press, Washington, D.C.
30. Volpi, R., Gerra, G., Vourna, S., Vescovi, P.P., Maestri, D., Chiodera, P., Coiro, V., 1992. Failure of the gamma-aminobutyric acid (GABA) derivate, baclofen, to stimulate growth hormone secretion in heroin addicts. Life Sciences 51, 247-251.
31. Willoughby, J.O., Jervois, P.M., Menadue, M.F., Blessing, W.N., 1986. Activation of GABA receptors in the hypothalamus stimulates secretion of growth hormone and prolactin. Brain Research 374, 119-124.